Glatopa is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Glatiramer Acetate.
Product ID | 63629-8816_7392939b-02ff-42c0-9120-2e24a2bf205f |
NDC | 63629-8816 |
Product Type | Human Prescription Drug |
Proprietary Name | Glatopa |
Generic Name | Glatiramer Acetate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2018-02-12 |
Marketing Category | ANDA / |
Application Number | ANDA206921 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | GLATIRAMER ACETATE |
Active Ingredient Strength | 40 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-09-10 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0781-3234 | Glatopa | Glatiramer Acetate |
0781-3250 | Glatopa | Glatiramer Acetate |
63629-8815 | Glatopa | Glatiramer Acetate |
63629-8816 | Glatopa | Glatiramer Acetate |
68546-317 | Copaxone | Glatiramer Acetate |
68546-325 | Copaxone | Glatiramer Acetate |
0378-6960 | Glatiramer Acetate | glatiramer acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GLATOPA 86390315 4819540 Live/Registered |
Novartis AG 2014-09-10 |
GLATOPA 85271930 not registered Dead/Abandoned |
Novartis AG 2011-03-21 |